125 related articles for article (PubMed ID: 17611295)
1. Validation of a viral and bacterial inactivation step during the extraction and purification process of porcine collagen.
Forest P; Morfin F; Bergeron E; Dore J; Bensa S; Wittmann C; Picot S; Renaud FN; Freney J; Gagnieu C
Biomed Mater Eng; 2007; 17(4):199-208. PubMed ID: 17611295
[TBL] [Abstract][Full Text] [Related]
2. Inactivation kinetics of model and relevant blood-borne viruses by treatment with sodium hydroxide and heat.
Borovec S; Broumis C; Adcock W; Fang R; Uren E
Biologicals; 1998 Sep; 26(3):237-44. PubMed ID: 10208725
[TBL] [Abstract][Full Text] [Related]
3. Virus safety of a porcine-derived medical device: evaluation of a viral inactivation method.
Hodde J; Hiles M
Biotechnol Bioeng; 2002 Jul; 79(2):211-6. PubMed ID: 12115437
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of virus in intravenous immunoglobulin G using solvent/detergent treatment and pasteurization.
Aghaie A; Pourfatollah AA; Bathaie SZ; Moazzeni SM; Khorsand Mohammad Pour H; Sharifi Z
Hum Antibodies; 2008; 17(3-4):79-84. PubMed ID: 19029665
[TBL] [Abstract][Full Text] [Related]
5. Virus inactivation by protein denaturants used in affinity chromatography.
Roberts PL; Lloyd D
Biologicals; 2007 Oct; 35(4):343-7. PubMed ID: 17517521
[TBL] [Abstract][Full Text] [Related]
6. Dry-heat treatment process for enhancing viral safety of an antihemophilic factor VIII concentrate prepared from human plasma.
Kim IS; Choi YW; Kang Y; Sung HM; Shin JS
J Microbiol Biotechnol; 2008 May; 18(5):997-1003. PubMed ID: 18633304
[TBL] [Abstract][Full Text] [Related]
7. Resistance of surface-dried virus to common disinfection procedures.
Terpstra FG; van den Blink AE; Bos LM; Boots AG; Brinkhuis FH; Gijsen E; van Remmerden Y; Schuitemaker H; van 't Wout AB
J Hosp Infect; 2007 Aug; 66(4):332-8. PubMed ID: 17601636
[TBL] [Abstract][Full Text] [Related]
8. [Validation of the virus inactivation capacity of a procedure of human plasma albumin purification by chromatography].
Stoltz JF; Geschier C; Rivat C; Sertillanges P; Grandgeorges M; Liautaud J; Regnault V; Dumont L
Ann Pharm Fr; 1993; 51(2):78-93. PubMed ID: 8250488
[TBL] [Abstract][Full Text] [Related]
9. Differential sensitivities of pathogens in red cell concentrates to Tri-P(4)-photoinactivation.
Trannoy LL; Terpstra FG; de Korte D; Lagerberg JW; Verhoeven AJ; Brand A; van Engelenburg FA
Vox Sang; 2006 Aug; 91(2):111-8. PubMed ID: 16907871
[TBL] [Abstract][Full Text] [Related]
10. Inactivation and clearance of viruses during the manufacture of high purity factor IX.
Johnston A; Macgregor A; Borovec S; Hattarki M; Stuckly K; Anderson D; Goss NH; Oates A; Uren E
Biologicals; 2000 Sep; 28(3):129-36. PubMed ID: 10964439
[TBL] [Abstract][Full Text] [Related]
11. Improvement of virus safety of an antihemophilc factor IX by virus filtration process.
Kim IS; Choi YW; Kang Y; Sung HM; Sohn KW; Kim YS
J Microbiol Biotechnol; 2008 Jul; 18(7):1317-25. PubMed ID: 18667862
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of adenovirus type 5 by caustics.
Jannat R; Hsu D; Maheshwari G
Biotechnol Prog; 2005; 21(2):446-50. PubMed ID: 15801784
[TBL] [Abstract][Full Text] [Related]
13. Validation of betapropiolactone (BPL) as an inactivant for infectious bovine rhinotracheitis (IBR) virus.
Kamaraj G; Lakshmi Narasu M; Srinivasan VA
Res Vet Sci; 2008 Dec; 85(3):589-94. PubMed ID: 18262212
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a novel, rapid-acting, sterilizing solution at room temperature.
Hobson DW; Seal LA
Am J Infect Control; 2000 Oct; 28(5):370-5. PubMed ID: 11029137
[TBL] [Abstract][Full Text] [Related]
15. Virus safety of avital bone tissue transplants: evaluation of sterilization steps of spongiosa cuboids using a peracetic acid-methanol mixture.
Pruss A; Kao M; Kiesewetter H; von Versen R; Pauli G
Biologicals; 1999 Sep; 27(3):195-201. PubMed ID: 10652175
[TBL] [Abstract][Full Text] [Related]
16. Effect of manufacturing process parameters on virus inactivation by dry heat treatment at 80 degrees C in factor VIII.
Roberts PL; Dunkerley C; McAuley A; Winkelman L
Vox Sang; 2007 Jan; 92(1):56-63. PubMed ID: 17181591
[TBL] [Abstract][Full Text] [Related]
17. The removal of model viruses, poliovirus type 1 and canine parvovirus, during the purification of human albumin using ion-exchange chromatographic procedures.
Cameron R; Davies J; Adcock W; MacGregor A; Barford JP; Cossart Y; Harbour C
Biologicals; 1997 Dec; 25(4):391-401. PubMed ID: 9467035
[TBL] [Abstract][Full Text] [Related]
18. [Inactivation of viruses in Factor XIII concentrate by pasteurization].
Mauler R; Hilfenhaus J
Arzneimittelforschung; 1984; 34(11):1524-7. PubMed ID: 6543127
[TBL] [Abstract][Full Text] [Related]
19. Purification of intravenous immunoglobulin G from human plasma--aspects of yield and virus safety.
Buchacher A; Iberer G
Biotechnol J; 2006 Feb; 1(2):148-63. PubMed ID: 16892245
[TBL] [Abstract][Full Text] [Related]
20. A membrane-based quantitative carrier test to assess the virucidal activity of disinfectants and persistence of viruses on porous fomites.
Mocé-Llivina L; Papageorgiou GT; Jofre J
J Virol Methods; 2006 Jul; 135(1):49-55. PubMed ID: 16563525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
